Hostname: page-component-76fb5796d-2lccl Total loading time: 0 Render date: 2024-04-28T08:32:28.779Z Has data issue: false hasContentIssue false
  • English
  • Français

Fluctuation of Viremia in Hepatitis B Virus–Infected Healthcare Workers Performing Exposure-Prone Procedures in the Netherlands

Published online by Cambridge University Press:  20 May 2016

Stijn F. H. Raven ,
Barry de Heus ,
Albert Wong ,
Hans L. Zaaijer  and
Jim E. van Steenbergen
Stijn F. H. Raven*
Affiliation:
Department of Infectious Diseases, Municipal Health Service West-Brabant, Breda, The Netherlands
Barry de Heus
Affiliation:
Centre of Infectious Diseases, Leiden University Medical Centre, Leiden, The Netherlands
Albert Wong
Affiliation:
Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands
Hans L. Zaaijer
Affiliation:
Sanquin Blood Supply Foundation, Department of Blood-Borne Infections, Amsterdam, The Netherlands Academic Medical Centre, Clinical Virology, Amsterdam, The Netherlands On behalf of the Dutch committee for prevention of iatrogenic HBV/HCV/HIV infection
Jim E. van Steenbergen
Affiliation:
Centre of Infectious Diseases, Leiden University Medical Centre, Leiden, The Netherlands Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands On behalf of the Dutch committee for prevention of iatrogenic HBV/HCV/HIV infection
*
Address correspondence to Stijn F. H. Raven, MD, GGD West-Brabant, PO Box 3024, 5003 DA Tilburg, The Netherlands (Stijn.Raven@radboudumc.nl).
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective

To determine the longitudinal changes in viral load of hepatitis B virus (HBV)–infected healthcare workers (HCWs) and its consequences for exclusion of infected HCWs performing exposure-prone procedures, various HBV DNA safety thresholds, and the frequency of monitoring.

Design

Retrospective cohort study June 1, 1996–January 31, 2013.

Participants

In the Netherlands, chronically HBV-infected HCWs performing exposure-prone procedures are notified to the Committee for Prevention of Iatrogenic Hepatitis B. Of the 126 notified HCWs, 45 had 2 or more HBV DNA levels determined without antiviral therapy.

Methods

A time-to-event analysis for HBV-infected HCWs categorized in various viremia levels surpassing a HBV DNA threshold level of 1×105 copies/mL, above which exposure-prone procedures are not allowed in the Netherlands.

Results

Fluctuations of HBV DNA in follow-up samples ranged from −5.4 to +2.2 log10 copies/mL. A high correlation was seen for each HBV DNA level with the 3 previous levels. In a time-to-event analysis, after 6 months 7.2%, 6.5%, and 14.3% of individuals had surpassed the threshold of 1×105 copies/mL for viral load categories 4.8×103 to 1.5×104; 1.5×104 to 4.0×104; and 4.0×104 to 1.0×105, respectively.

Conclusions

We propose standard retesting every 6 months, with more frequent retesting just below the high threshold value (1×105 copies/mL), and prolonging this standard interval to 1 year after 3 consecutive levels below the threshold in policies with lower safety thresholds (1×103 or 1×104 copies/mL).

Infect Control Hosp Epidemiol 2016;37:655–660

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 37 , Issue 6 , June 2016 , pp. 655 - 660
Copyright
© 2016 by The Society for Healthcare Epidemiology of America. All rights reserved 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

S.F.H.R. and B.d.H. contributed equally to this article.

References

1. World Health Organization (WHO). Hepatitis B factsheet 204. WHO website. http://www.who.int/mediacentre/factsheets/fs204/en/ Accessed December 9, 2014.Google Scholar
2. Gerlich, WH. Prophylactic vaccination against hepatitis B: achievements, challenges and perspectives. Med Microbiol Immunol 2015;204:39–55.Google Scholar
3. Ott, JJ, Stevens, GA, Groeger, J, Wiersma, ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 2012;30:2212–2219.CrossRefGoogle ScholarPubMed
4. Garibaldi, RA, Rasmussen, CM, Holmes, AW, Gregg, MB. Hospital-acquired serum hepatitis. Report of an outbreak. JAMA 1972;219:1577–1580.Google Scholar
5. Carlson, AL, Perl, TM. Health care workers as source of hepatitis B and C virus transmission. Clin Liver Dis 2010;14:153–168.Google Scholar
6. Gunson, RN, Shouval, D, Roggendorf, M, et al. Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in health care workers (HCWs): guidelines for prevention of transmission of HBV and HCV from HCW to patients. J Clin Virol 2003;27:213–230.Google Scholar
7. Deuffic-Burban, S, Delarocque-Astagneau, E, Abiteboul, D, Bouvet, E, Yazdanpanah, Y. Blood-borne viruses in health care workers: prevention and management. J Clin Virol 2011;52:4–10.Google Scholar
8. Landelijke richtlijn preventie transmissie van hepatitis B van medisch personeel naar patiënten. http://www.rivm.nl/dsresource?objectid=rivmp:53526&type=org&disposition=inline&ns_nc=1. Published 2012. Accessed December 10, 2014.Google Scholar
9. UK Department of Health. Hepatitis B infected healthcare workers and antiviral therapy. http://webarchive.nationalarchives.gov.uk/20130107105354/http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_073164. Published 2007. Accessed May 10, 2015.Google Scholar
10. Centers for Disease Control and Prevention. Updated CDC recommendations for the management of hepatitis B virus-infected health-care providers and students. MMWR Recomm Rep 2012;61:1–12.Google Scholar
11. Henderson, DK, Dembry, L, Fishman, NO, et al. SHEA guideline for management of healthcare workers who are infected with hepatitis B virus, hepatitis C virus, and/or human immunodeficiency virus. Infect Control Hosp Epidemiol 2010;31:203–232.Google Scholar
12. Buster, EH, van der Eijk, AA, Schalm, SW. Doctor to patient transmission of hepatitis B virus: implications of HBV DNA levels and potential new solutions. Antiviral Res 2003;60:79–85.CrossRefGoogle ScholarPubMed
13. Corden, S, Ballard, AL, Ijaz, S, et al. HBV DNA levels and transmission of hepatitis B by health care workers. J Clin Virol 2003;27:52–58.Google Scholar
14. Updted CDC recommendations for the management of hepatitis B virus-infected health-care providers and students. MMWR Recomm Rep 2012;61:1–12.Google Scholar
15. Tedder, RS, Ijaz, S, Gilbert, N, et al. Evidence for a dynamic host-parasite relationship in e-negative hepatitis B carriers. J Med Virol 2002;68:505–512.Google Scholar
16. Plentz, A, Koller, G, Weinberger, KM, Jilg, W. Precision and stability of hepatitis B virus DNA levels in chronic surface antigen carriers. J Med Virol 2004;73:522–528.Google Scholar
17. Martinot-Peignoux, M, Boyer, N, Colombat, M, et al. Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers. J Hepatol 2002;36:543–546.CrossRefGoogle ScholarPubMed
18. Cacciola, I, Spatari, G, Pollicino, T, et al. Virological profiles in hepatitis B virus inactive carriers: monthly evaluation in 1-year follow-up study. Liver Int 2005;25:555–563.CrossRefGoogle ScholarPubMed
19. Daha, TJ, Bilkert-Mooiman, MA, Ballemans, C, et al. Hepatitis B virus infected health care workers in the Netherlands, 2000-2008. Eur J Clin Microbiol Infect Dis 2009;28:1041–1044.Google Scholar
20. Nardone, A, Anastassopoulou, CG, Theeten, H, et al. A comparison of hepatitis B seroepidemiology in ten European countries. Epidemiol Infect 2009;137:961–969.Google Scholar
21. Lok, AS, McMahon, BJ. Chronic hepatitis B: update 2009. Hepatology 2009;50:661–662.Google Scholar
22. Croagh, CM, Bell, SJ, Chen, RY, Locarnini, S, Desmond, PV. Longitudinal observation of viral load changes in untreated HBeAg negative chronic hepatitis B. Acta Gastroenterol Belg 2013;76:275–281.Google Scholar
23. FitzSimons, D, Francois, G, De Carli, G, et al. Hepatitis B virus, hepatitis C virus and other blood-borne infections in healthcare workers: guidelines for prevention and management in industrialised countries. Occup Environ Med 2008;65:446–451.Google Scholar
24. Papatheodoridis, GV, Chrysanthos, N, Hadziyannis, E, Cholongitas, E, Manesis, EK. Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infection. J Viral Hepat 2008;15:434–441.Google Scholar
25. Chen, CJ, Yang, HI, Su, J, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006;295:65–73.Google Scholar
26. European Association for the Study of the Liver. EASL clinical practice guidelines: management of chronic hepatitis B virus infection. J Hepatol 2012;57:167–185.Google Scholar
27. Bhat, M, Ghali, P, Deschenes, M, Wong, P. Hepatitis B and the infected health care worker: public safety at what cost? Can J Gastroenterol 2012;26:257–260.Google Scholar
28. van der Eijk, AA, de Man, RA, Niesters, HG, Schalm, SW, Zaaijer, HL. Hepatitis B virus (HBV) DNA levels and the management of HBV-infected health care workers. J Viral Hepat 2006;13:2–4.Google Scholar
29. Alexopoulou, A, Karayiannis, P. HBeAg negative variants and their role in the natural history of chronic hepatitis B virus infection. World J Gastroenterol 2014;20:7644–7652.CrossRefGoogle ScholarPubMed
30. Caliendo, AM, Valsamakis, A, Bremer, JW, et al. Multilaboratory evaluation of real-time PCR tests for hepatitis B virus DNA quantification. J Clin Microbiol 2011;49:2854–2858.Google Scholar
31. Yang, JF, Lin, YY, Huang, JF, et al. Comparison of clinical application of the Abbott HBV PCR kit and the VERSANT HBV DNA 3.0 test to measure serum hepatitis B virus DNA in Taiwanese patients. Kaohsiung J Med Sci 2009;25:413–422.Google Scholar
32. Schalm, SW, Buster, EH. Management of hepatitis B virus infected health care workers based on HBV DNA levels. J Clin Virol 2003;27:231–234.CrossRefGoogle ScholarPubMed